DHT.U (DHT.U) News
Track canonical SquawkNews coverage tagged to DHT.U, DHT.U. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Dri Healthcare Trust to buy Tavapadon royalty for US$316 million
Dri Healthcare Trust (TSX:DHT.U) announced a US$316 million purchase of the Tavapadon royalty.
MNA | Sep 21, 2026, 12:13 PM UTC
M
DRI Healthcare agrees $316 million purchase of tavapadon royalties
DRI Healthcare Trust said it entered purchase agreements to buy certain royalty participation rights tied to U.S. net sales of tavapadon, an investigational Parkinson’s disease drug candidate.
MNA | Sep 21, 2026, 11:35 AM UTC
M
DRI Healthcare Trust to buy Tavapadon royalty for $316M
DRI Healthcare Trust announced a $316M purchase of the Tavapadon royalty.
MNA | Sep 21, 2026, 11:00 AM UTC